Budgeting 101 Why Verve Therapeutics Zoomed 40% Higher This WeekBy Dan Brown18/04/20250 Good news from the laboratory and a clutch of bullish analyst notes were the drivers behind Verve Therapeautics’ (VERV 2.00%) big…
